학술논문

Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
Document Type
Author
Jansen, Ris E.van der Lee, Sven J.Gomez-Fonseca, Duberde Rojas, ItziarDalmasso, Maria CarolinaGrenier-Boley, BenjaminZettergren, AnnaMishra, AniketAli, MuhammadAndrade, VictorBellenguez, CelineKleineidam, LucaKucukali, FahriSung, Yun JuTesi, NiccoloVromen, Ellen M.Wightman, Douglas P.Alcolea, DanielAlegret, MontserratAlvarez, IgnacioAmouyel, PhilippeAthanasiu, LaviniaBahrami, ShahramBailly, HenriBelbin, OliviaBergh, SverreBertram, LarsBiessels, Geert JanBlennow, KajBlesa, RafaelBoada, MerceBoland, AnneBuerger, KatharinaCarracedo, AngelCervera-Carles, LauraChene, GenevieveClaassen, Jurgen A. H. R.Debette, StephanieDeleuze, Jean-Francoisde Deyn, Peter PaulDiehl-Schmid, JanineDjurovic, SrdjanDols-Icardo, OriolDufouil, CaroleDuron, EmmanuelleDuezel, EmrahFladby, TormodFortea, JuanFroelich, LutzGarcia-Gonzalez, PabloGarcia-Martinez, MariaGiegling, InaGoldhardt, OliverGobom, JohanGrimmer, TimoHaapasalo, AnnakaisaHampel, HaraldHanon, OlivierHausner, LucreziaHeilmann-Heimbach, StefanieHelisalmi, SeppoHeneka, Michael T.Hernandez, IsabelHerukka, Sanna-KaisaHolstege, HenneJarholm, JonasKern, SilkeKnapskog, Anne-BritaKoivisto, Anne M.Kornhuber, JohannesKuulasmaa, TeemuLage, CarmenLaske, ChristophLeinonen, VilleLewczuk, PiotrLleo, Albertode Munain, Adolfo LopezLopez-Garcia, SaraMaier, WolfgangMarquie, MartaMol, Merel O.Montrreal, LauraMoreno, FerminMoreno-Grau, SoniaNicolas, GaelNothen, Markus M.Orellana, AdelinaPalhaugen, LenePapma, Janne M.Pasquier, FlorencePerneczky, RobertPeters, OliverPijnenburg, Yolande A. L.Popp, JuliusPosthuma, DaniellePozueta, AnaPriller, JosefPuerta, RaquelQuintela, InesRamakers, InezRodriguez-Rodriguez, EloyRujescu, DanSaltvedt, IngvildSanchez-Juan, PascualScheltens, PhilipScherbaum, NorbertSchmid, MatthiasSchneider, AnjaSelbaek, GeirSelnes, PerShadrin, AlexeySkoog, IngmarSoininen, HilkkaTarraga, LluisTeipel, StefanTijms, BettyTsolaki, MagdaVan Broeckhoven, ChristineVan Dongen, Jaspervan Swieten, John C.Vandenberghe, RikVidal, Jean-SebastienVisser, Pieter J.Vogelgsang, JonathanWaern, MargdaWagner, MichaelWiltfang, JensWittens, Mandy M. J.Zetterberg, HenrikZulaica, Mirenvan Duijn, Cornelia M.Bjerke, MariaEngelborghs, SebastiaanJessen, FrankTeunissen, Charlotte E.Pastor, PauHiltunen, MikkoIngelsson, MartinAndreassen, Ole A.Clarimon, JordiSleegers, KristelRuiz, AgustinRamirez, AlfredoCruchaga, CarlosLambert, Jean-Charlesvan der Flier, Wiesje
Source
Acta Neuropathologica. 144(5):821-842
Subject
GWAS
Alzheimer's disease
Cerebrospinal fluid
Amyloid-beta
Tau
Language
English
Abstract
Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) reflect core features of the pathogenesis of Alzheimer’s disease (AD) more directly than clinical diagnosis. Initiated by the European Alzheimer & Dementia Biobank (EADB), the largest collaborative effort on genetics underlying CSF biomarkers was established, including 31 cohorts with a total of 13,116 individuals (discovery n = 8074; replication n = 5042 individuals). Besides the APOE locus, novel associations with two other well-established AD risk loci were observed; CR1 was shown a locus for Aβ42 and BIN1 for pTau. GMNC and C16orf95 were further identified as loci for pTau, of which the latter is novel. Clustering methods exploring the influence of all known AD risk loci on the CSF protein levels, revealed 4 biological categories suggesting multiple Aβ42 and pTau related biological pathways involved in the etiology of AD. In functional follow-up analyses, GMNC and C16orf95 both associated with lateral ventricular volume, implying an overlap in genetic etiology for tau levels and brain ventricular volume.